Neil Averitt commentary: Challenges to bad-faith patent claims on the horizon
The FTC is likely to start moving more aggressively against unwarranted, bad-faith assertions of patent rights. The recent AndroGel complaint sets down a marker on that. However, the exact breadth of...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: